|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/00 |
| (11) | Number of the document | 3209691 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15794641.9 |
| Date of filing the European patent application | 2015-10-21 | |
| (97) | Date of publication of the European application | 2017-08-30 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2015/058124 |
| Date | 2015-10-21 |
| (87) | Number | WO 2016/063233 |
| Date | 2016-04-28 |
| (30) | Number | Date | Country code |
| 14190370 | 2014-10-24 | EP |
| (72) |
POIRIER, Nicolas, FR
VANHOVE, Bernard, FR
|
| (73) |
OSE Immunotherapeutics,
22 Boulevard Benoni Goullin, 44200 Nantes,
FR
|
| (54) | COMPOSITIONS FOR INDUCING DIFFERENTIATION OF MYELOID DERIVED SUPPRESSOR CELL TO TREAT CANCER AND INFECTIOUS DISEASES |
| COMPOSITIONS FOR INDUCING DIFFERENTIATION OF MYELOID DERIVED SUPPRESSOR CELL TO TREAT CANCER AND INFECTIOUS DISEASES |